Structure of the calcium pyrophosphate monohydrate phase (Ca2P2O7·H2O): towards understanding the dehydration process in calcium pyrophosphate hydrates

Calcium pyrophosphate hydrate (CPP, Ca₂P₂O₇·nH₂O) and calcium orthophosphate compounds (including apatite, octacalcium phosphate etc.) are among the most prevalent pathological calcifications in joints. Even though only two dihydrated forms of CPP (CPPD) have been detected in vivo (monoclinic and triclinic CPPD), investigations of other hydrated forms such as tetrahydrated or amorphous CPP are relevant to a further understanding of the physicochemistry of those phases of biological interest. The synthesis of single crystals of calcium pyrophosphate monohydrate (CPPM; Ca₂P₂O₇·H₂O) by diffusion in silica gel at ambient temperature and the structural analysis of this phase are reported in this paper. Complementarily, data from synchrotron X‐ray diffraction on a CPPM powder sample have been fitted to the crystal parameters. Finally, the relationship between the resolved structure for the CPPM phase and the structure of the tetrahydrated calcium pyrophosphate β phase (CPPT‐β) is discussed.     

Circulating Levels of Dephosphorylated-Uncarboxylated Matrix Gla Protein in Patients with Acute Coronary Syndrome

Vascular calcification contributes to the pathogenesis of coronary artery disease while matrix Gla protein (MGP) was recently identified as a potent inhibitor of vascular calcification. MGP fractions, such as dephosphorylated-uncarboxylated MGP (dp-ucMGP), lack post-translational modifications and are less efficient in vascular calcification inhibition. We sought to compare dp-ucMGP levels between patients with acute coronary syndrome (ACS), stratified by ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) status. Physical examination and clinical data, along with plasma dp-ucMGP levels, were obtained from 90 consecutive ACS patients. We observed that levels of dp-ucMGP were significantly higher in patients with NSTEMI compared to STEMI patients (1063.4 ± 518.6 vs. 742.7 ± 166.6 pmol/L, p < 0.001). NSTEMI status and positive family history of cardiovascular diseases were only independent predictors of the highest tertile of dp-ucMGP levels. Among those with NSTEMI, patients at a high risk of in-hospital mortality (adjudicated by GRACE score) had significantly higher levels of dp-ucMGP compared to non-high-risk patients (1417.8 ± 956.8 vs. 984.6 ± 335.0 pmol/L, p = 0.030). Altogether, our findings suggest that higher dp-ucMGP levels likely reflect higher calcification burden in ACS patients and might aid in the identification of NSTEMI patients at increased risk of in-hospital mortality. Furthermore, observed dp-ucMGP levels might reflect differences in atherosclerotic plaque pathobiology between patients with STEMI and NSTEMI.     

Vibrational Spectral Biodiagnosis of Ocular Calcification

Abstract

Ocular calcification is a biological mineralization. It is also a well-known human ophthalmic disease but is a complex process because the pathophysiology of calcium deposition in ocular tissues depends on site-specific factors. Calcified deposits in the eyes are asymptomatic lesions; a serious consequence of ocular plaques is the potential partial or total loss of vision in the affected eye. Therefore, a better understanding of the exact compositional components and origin of calcified plaques in different eye tissues is necessary and merits exploration. The present review article includes information on different diagnostic or analytical techniques to examine human ocular calcification collected and compiled from 2005 to 2013, together with data on the application of vibrational spectroscopy in ophthalmology studies from 1990 onwards. This overview of ocular calcification is mainly focused on two aspects: the pathogenesis and mechanism of calcification in different ocular tissues and biomedical applications of vibrational spectroscopy to spectral biodiagnosis of eye tissues. A summary of the in vitro, in situ, and in vivo spectral information that is expected to assist physicians in the diagnosis and treatment of patients or satisfy patients of the clinical competence of the diagnosis is provided.     

Microstructural characterization of CPPD and hydroxyapatite crystal depositions on human menisci

Meniscus is a fibrocartilaginous tissue composed mainly of water and a dense elaborate collagen network with a predominantly circumferential alignment. Crystal formation and accumulation on meniscal tissue is frequently observed especially in elderly. In this study, we used X‐ray diffraction (XRD), FTIR and FT‐Raman for the structural identification of the depositions and Optical microscopy, Scanning Electron microscopy (SEM/EDX) and Atomic Force microscopy (AFM), in order to investigate the structural relationship between the crystal deposits and the collagen fibers of human meniscal tissues. We are reporting on the formation of intercalary “colonies” of Calcium Pyrophosphate Dihydrate (CPPD) crystals with two distinct morphologies corresponding to the monoclinic and the triclinic phase, as well as the formation of micro‐aggregations composed of nano‐crystalline HAP aggregations which are developed along the longitudinal axis of collagen fibers without extensively disturbing the collagens arrangement.     

Bioactive Properties of Chitin/Chitosan—Calcium Phosphate Composite Materials

Calcium phosphate coating over phosphorylated derivatives of chitin/chitosan material was produced by a process based on phosphorylation, Ca(OH)₂ treatment and SBF (simulated body fluid solution) immersion. Chitin/chitosan phosphorylated using urea and H₃PO₄ and then soaked in saturated Ca(OH)₂ solution at ambient temperature, which lead to the formation of thin coatings formed by partial hydrolysis of the PO₄ functionalities, were found to stimulate the growth of a calcium phosphate coating on their surfaces after soaking in 1.5 × SBF solution for as little as one day. The Ca(OH)₂ treatment facilitates the formation of a calcium phosphate precursor over the phosphorylated chitin/chitosan, which in turn encourages the growth of a calcium deficient apatite coating over the surface upon immersion in SBF solution. The bio-compatibility of calcium phosphate compound—chitin/chitosan composite materials was evaluated by cell culture test using L-929 cells. The initial anchoring ratio and the adhesive strength of L-929 cells for composites was higher than that for the polystyrene disk (LUX, control). The results of in-vitro evaluation suggested that the calcium phosphate—chitin/chitosan composite materials were suitable for cell carrier materials.     

Effect of Motif‐Programmed Artificial Proteins on the Calcium Uptake in a Synthetic Hydrogel

Motif‐programmed artificial proteins with mineralization‐related activity were covalently immobilized onto the surface of a hydrogel, poly(2‐hydroxyethyl methacrylate) (PHEMA). We investigated the influence of assaying conditions upon the ability of three selected proteins (PS64, PS382 and PS458) to modulate calcification in vitro. A long‐term assay measuring the real amount of calcium phosphate phase in the protein‐modified PHEMA showed that all proteins enhanced the uptake of calcium by the hydrogel. For PS382 and PS458, this is a behaviour opposite to that displayed when the same proteins were tested in a free state by a rapid solution assay. Such difference may be attributed to a restricted mobility of the proteins due to immobilization.

     

Transitions and heteroclinic cycles in the general Gierer-Meinhardt equation and cardiovascular calcification model

The article is concerned with transitions and pattern selection analysis of the inhibitor-activator system proposed in connection with recent studies of cardiovascular calcification patterns. Explicit criteria are derived to enable us to distinguish between stable and metastable patterns. By deriving a reduced system of equations, the existence of certain complicated structures is discussed; in particular, heteroclinic cycles are identified and their properties are studied. It is also discussed that the change of boundary conditions can affect the transitions of the system. In this connection, we will also study asymptotic behavior of patterns after transitions and will compare the results with numerical simulations.     

Degradation and calcification in vitro of new bioresorbable terpolymers of lactides with an improved degradation pattern

Experimental implants produced from poly(l-lactide/?-caprolactone/glycolide) 80/10/10% (polymer 1), poly(l-lactide/dl-lactide/glycolide) 80/10/10% (polymer 2) and poly(l-lactide/dl-lactide/glycolide) 80/5/15% (polymer 3) were subjected to in vitro degradation in a buffer solution at 37 °C and pH = 7.4 and calcification in vitro was performed at 37 °C in a simulated body fluid for 4, 8, 12, 16, 24, 28, 32 and 36 weeks. In vitro degradation was performed in static and pseudodynamic modes. Samples from poly(l-lactide) were used as a control. The changes in the materials during the course of degradation were assessed from the measurements of molecular weight, mechanical properties and crystallinity. The changes in the appearance of the materials upon degradation and calcification were observed using a scanning electron microscope with an EDAX attachment. The decrease of molecular weight at 4 weeks was 66% for polymer 1, 56% for polymer 2 and 20% for polymer 3. Samples retained 55% of their bending strength at 4 weeks (polymer 1), 50% at 12 weeks (polymer 2) and 99% at 12 weeks (polymer 3). The bending modulus of polymer 3 remained practically unchanged during the first 12 weeks of degradation. Subsequently it increased by 44% at week 16 and remained unchanged up to 24 weeks and next decreased to 33% of the initial value at the end of the experiment at week 32. The bending modulus of polymer 2 decreased 35% at week 8 and subsequently increased to 44% of the initial value at week 16 and remained at this level until week 20. Next the modulus decreased to 84% of the initial value at week 24. The bending modulus of polymer 1 progressively decreased over the first 12 weeks of degradation to 40% of the initial value. The maximum crystallinity attained by the samples at the end of the experiments was 60% for polymer 1 and 38% for polymers 2 and 3. In the static mode the pH remained constant up to week 8 for polymer 1, week 20 for polymer 2 and week 28 for polymer 3. It decreased to 3.8 at weeks 12, 20 and 36 for polymers 1, 2 and 3, respectively. All the samples underwent calcification from week 16 of the experiments with the Ca/P ratio ranging from 0.92 to 1.20.     

Calcification resistance of polyisobutylene and polyisobutylene‐based materials

Calcification of implanted biomaterials is highly undesirable and limits clinical applicability. Experiments were carried out to assess the calcification resistance of polyisobutylene (PIB), PIB‐based polyurethane (PIB‐PU), PIB‐PU reinforced with (CH₃)₃N⁺CH₂CH₂CH₂NH₂ I^?‐modified montmorillonite (PIB‐PU/nc), PIB‐based polyurethane urea (PIB‐PUU), PIB‐PU containing S atoms (PIB_S‐PU), PIB_S‐PU reinforced with (CH₃)₃N⁺CH₂CH₂CH₂NH₂ I^?‐modified montmorillonite (PIB_S‐PU/nc), and poly(isobutylene‐b‐styrene‐b‐isobutylene) (SIBS), relative to that of a clinically widely implanted polydimethylsiloxane (PDMS)–based PU, Elast‐Eon (the “control”). Samples were incubated in simulated body fluid for 28 days at 37°C, and the extent of surface calcification was analyzed by scanning electron microscopy (SEM), atomic force microscopy (AFM), energy‐dispersive X‐ray spectroscopy (EDX), X‐ray photoelectron spectroscopy (XPS), and Fourier‐transform‐infrared (FT‐IR) spectroscopy. Whereas the PDMS‐based PU showed extensive calcification, PIB and PIB‐PU containing 72.5% PIB, ie, a polyurethane whose surface is covered with PIB, were free of calcification. PIB_S‐PU and PIB‐PUU, ie, polyurethanes that contain S or urea groups, respectively, were slightly calcified. The amine‐modified montmorillonite‐reinforcing agent reduced the extent of calcification. SIBS was found slightly calcified. Evidently, PIB and materials fully coated with PIB are calcification resistant.